Record breaking Pharma M&A for 2022?
"The pharmaceutical industry appears poised for a record-breaking level of merger and acquisition (M&A) activity in 2022. Four emerging trends back up this assertion. ------------------- First,Pfizer(NYSE:PFE)andModernaare both flush with cash thanks to their novel coronavirus vaccines. ------------------------ Second,Novartisrecently banked $21 billion after selling its two decade long position inRoche. ------------------------ Third,Amgen,AstraZeneca,Biogen,Bristol Myers Squibb,Gilead Sciences,Johnson & Johnson,Merck, Moderna, Pfizer, andSanofiare all expected to pursue bolt-on acquisitions next year to flesh out their clinical pipelines and product portfolios. ------------------------------------- Fourth,Novo Nordiskand Roche can both be counted on for at least one small to mid-sized acquisition peryear." ------------------------------------ These trends look promising fir ONC. Cheers!!!